Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1201-1220 of 2,360 trials

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

NCT04692688

The objective of this study is to evaluate the safety and efficacy of APX3330 to treat diabetic retinopathy (DR) and diabetic macular edema (DME).

Diabetic RetinopathyDiabetic Macular EdemaNPDR - Non Proliferative Diabetic Retinopathy+1 more

Ocuphire Pharma, Inc.103 participantsStarted Apr 2021

Phoenix, Arizona, United States • Bakersfield, California, United States • Beverly Hills, California, United States +21 more locations

COMPLETEDPhase 1< 1 mile

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

NCT04862741

This is a Phase 1b, randomized, double-blind, multicenter dose-ranging study to evaluate the safety, tolerability, and PK of NX-13. Approximately 40 subjects will be randomized in a 3:3:3:1 ratio to receive 1 of 3 NX-13 treatment regimens (NX-13 250 mg IR, 500 mg IR, 500 mg MR) (12 evaluable subjects at each of the 3 dose levels) or placebo (4 subjects), once daily for 28 consecutive days.

Ulcerative Colitis

Landos Biopharma Inc.39 participantsStarted May 2021

Huntsville, Alabama, United States • Lancaster, California, United States • Mission Viejo, California, United States +28 more locations

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Rheumatoid Arthritis Trials in Other Cities

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Safety and Efficacy in Adult Subjects With Acute Migraines

Trial in Adult Subjects With Acute Migraines

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Expanded Access Protocol Using 131I-MIBG

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Bacteriophage Therapy in Patients With Urinary Tract Infections

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

Other Conditions in San Antonio